ICON Cancer Care Hobart

Hobart, Tasmania 7000

0 studies enrolling now · 1 studies all time

What they study most

Early Breast Cancer

Studies at this site

• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling